Multifocal osteoarthritis due toCandida albicans in a neonate: Serum level monitoring of liposomal amphotericin B and literature review
- 60 Downloads
A 32-week neonate weighing 2,300 g at birth with fungemia due toCandida albicans subsequently developed multifocal osteoarthritis of the lower extremities due to the same organism during therapy with amphotericin B (0.5 mg/kg/day) and flucytosine (100 mg/kg/day) to which the isolates were susceptible. Liposomal amphotericin B (3.5 mg/kg/day) was substituted for conventional amphotericin B and complete clinical and radiologic recovery as well as sterilization of affected joints were achieved with a 38-day-course (144.5 mg/kg total). Adequate drug concentrations in serum and synovial fluid were attained with liposomal amphotericin B. Nine neonates (≤28 days of age) with bone and/or joint infections due toCandida spp. had previously been reported in the English-language literature. To our knowledge, the present case is the first reported cure with liposomal amphotericin B. Previous cases are reviewed and the potential role of liposomal amphotericin B in this serious neonatal infection is discussed.
KeywordsOsteoarthritis Drug Concentration Lower Extremity Amphotericin Synovial Fluid
Unable to display preview. Download preview PDF.
- 1.Feigin, R. D., Adcock, L. M., Edwards, M. S. Fungal and protozoal infections. In:Fanaroff, A. A., Martin, R. J. (eds.): Neonatal-perinatal medicine — diseases of the fetus and infant. Mosby-Year Book Inc, St Louis 1992, pp. 683–690.Google Scholar
- 12.National Committee for Clinical Laboratory Standards: Reference method for broth dilution antifungal susceptibility testing of yeasts; proposed standard. NCCLS document M27-P (ISBN 1-56238-186-5). NCCLS, Villanova, PA 1992.Google Scholar
- 27.Lackner, H., Schiwinger, W., Urban, C., Muller, W., Ritschl, E., Reiterer, F., Kuttnig-Haim, M., Urlesberger, B., Hauer, C. Liposomal amphotericin-B (AmBisome) for treatment of disseminated fungal infections in two infants of very low birth weight. Pediatrics 89 (1992) 1259–1261.PubMedGoogle Scholar
- 28.daSilva, L. P., Amaral, J. M. V., Ferreira, N. C. Which is the most appropriate dosage of liposomal amphotericin B (AmBisome) for the treatment of fungal infections in infants of very low birth weight? Pediatrics 91 (1993) 1217–1218.Google Scholar
- 29.Bennett, J. E. Antifungal agents. In:Mandell, G. L., Bennett, J. E., Dolin, R. (eds.): Principles and practice of infectious diseases. Churchill Livingstone, New York 1995, pp. 401–410.Google Scholar